nodes	percent_of_prediction	percent_of_DWPC	metapath
Eletriptan—HTR2B—Sorafenib—thyroid cancer	0.231	0.397	CbGbCtD
Eletriptan—CYP2C19—Sorafenib—thyroid cancer	0.0594	0.102	CbGbCtD
Eletriptan—CYP2C9—Sorafenib—thyroid cancer	0.0493	0.0846	CbGbCtD
Eletriptan—ABCB1—Sorafenib—thyroid cancer	0.0479	0.0821	CbGbCtD
Eletriptan—CYP3A4—Vandetanib—thyroid cancer	0.0476	0.0816	CbGbCtD
Eletriptan—CYP2D6—Sorafenib—thyroid cancer	0.0451	0.0774	CbGbCtD
Eletriptan—ABCB1—Doxorubicin—thyroid cancer	0.0291	0.0498	CbGbCtD
Eletriptan—CYP3A4—Sorafenib—thyroid cancer	0.0287	0.0492	CbGbCtD
Eletriptan—CYP2D6—Doxorubicin—thyroid cancer	0.0274	0.047	CbGbCtD
Eletriptan—CYP3A4—Doxorubicin—thyroid cancer	0.0174	0.0299	CbGbCtD
Eletriptan—Dyspnoea—Sorafenib—thyroid cancer	0.000661	0.00194	CcSEcCtD
Eletriptan—Dry eye—Doxorubicin—thyroid cancer	0.000656	0.00193	CcSEcCtD
Eletriptan—Lymphadenopathy—Epirubicin—thyroid cancer	0.000653	0.00192	CcSEcCtD
Eletriptan—Nausea—Vandetanib—thyroid cancer	0.000652	0.00192	CcSEcCtD
Eletriptan—Dyspepsia—Sorafenib—thyroid cancer	0.000652	0.00191	CcSEcCtD
Eletriptan—Oesophagitis—Doxorubicin—thyroid cancer	0.000649	0.0019	CcSEcCtD
Eletriptan—Rash maculo-papular—Doxorubicin—thyroid cancer	0.000645	0.00189	CcSEcCtD
Eletriptan—Decreased appetite—Sorafenib—thyroid cancer	0.000644	0.00189	CcSEcCtD
Eletriptan—Thrombophlebitis—Epirubicin—thyroid cancer	0.000644	0.00189	CcSEcCtD
Eletriptan—Blood alkaline phosphatase increased—Epirubicin—thyroid cancer	0.000641	0.00188	CcSEcCtD
Eletriptan—Gastrointestinal disorder—Sorafenib—thyroid cancer	0.00064	0.00188	CcSEcCtD
Eletriptan—Fatigue—Sorafenib—thyroid cancer	0.000639	0.00188	CcSEcCtD
Eletriptan—Constipation—Sorafenib—thyroid cancer	0.000634	0.00186	CcSEcCtD
Eletriptan—Pain—Sorafenib—thyroid cancer	0.000634	0.00186	CcSEcCtD
Eletriptan—Vascular purpura—Epirubicin—thyroid cancer	0.000623	0.00183	CcSEcCtD
Eletriptan—Hypertonia—Doxorubicin—thyroid cancer	0.000622	0.00183	CcSEcCtD
Eletriptan—Eczema—Epirubicin—thyroid cancer	0.00062	0.00182	CcSEcCtD
Eletriptan—Abnormal vision—Doxorubicin—thyroid cancer	0.000619	0.00182	CcSEcCtD
Eletriptan—Eye pain—Epirubicin—thyroid cancer	0.000617	0.00181	CcSEcCtD
Eletriptan—Mental disability—Doxorubicin—thyroid cancer	0.000616	0.00181	CcSEcCtD
Eletriptan—Gastrointestinal pain—Sorafenib—thyroid cancer	0.000606	0.00178	CcSEcCtD
Eletriptan—Lymphadenopathy—Doxorubicin—thyroid cancer	0.000604	0.00177	CcSEcCtD
Eletriptan—Thrombophlebitis—Doxorubicin—thyroid cancer	0.000595	0.00175	CcSEcCtD
Eletriptan—Increased appetite—Epirubicin—thyroid cancer	0.000593	0.00174	CcSEcCtD
Eletriptan—Blood alkaline phosphatase increased—Doxorubicin—thyroid cancer	0.000593	0.00174	CcSEcCtD
Eletriptan—Dermatitis exfoliative—Epirubicin—thyroid cancer	0.00059	0.00173	CcSEcCtD
Eletriptan—Urticaria—Sorafenib—thyroid cancer	0.000589	0.00173	CcSEcCtD
Eletriptan—Abdominal pain—Sorafenib—thyroid cancer	0.000586	0.00172	CcSEcCtD
Eletriptan—Body temperature increased—Sorafenib—thyroid cancer	0.000586	0.00172	CcSEcCtD
Eletriptan—Purpura—Epirubicin—thyroid cancer	0.000578	0.0017	CcSEcCtD
Eletriptan—Vascular purpura—Doxorubicin—thyroid cancer	0.000576	0.00169	CcSEcCtD
Eletriptan—Eczema—Doxorubicin—thyroid cancer	0.000574	0.00168	CcSEcCtD
Eletriptan—Eye pain—Doxorubicin—thyroid cancer	0.000571	0.00168	CcSEcCtD
Eletriptan—Diplopia—Epirubicin—thyroid cancer	0.000557	0.00164	CcSEcCtD
Eletriptan—Osteoarthritis—Epirubicin—thyroid cancer	0.000557	0.00164	CcSEcCtD
Eletriptan—Increased appetite—Doxorubicin—thyroid cancer	0.000549	0.00161	CcSEcCtD
Eletriptan—Affect lability—Epirubicin—thyroid cancer	0.000548	0.00161	CcSEcCtD
Eletriptan—Migraine—Epirubicin—thyroid cancer	0.000548	0.00161	CcSEcCtD
Eletriptan—Dermatitis exfoliative—Doxorubicin—thyroid cancer	0.000546	0.0016	CcSEcCtD
Eletriptan—Hypersensitivity—Sorafenib—thyroid cancer	0.000546	0.0016	CcSEcCtD
Eletriptan—Face oedema—Epirubicin—thyroid cancer	0.000538	0.00158	CcSEcCtD
Eletriptan—Purpura—Doxorubicin—thyroid cancer	0.000535	0.00157	CcSEcCtD
Eletriptan—Asthenia—Sorafenib—thyroid cancer	0.000532	0.00156	CcSEcCtD
Eletriptan—Mood swings—Epirubicin—thyroid cancer	0.000528	0.00155	CcSEcCtD
Eletriptan—Pruritus—Sorafenib—thyroid cancer	0.000524	0.00154	CcSEcCtD
Eletriptan—Ataxia—Epirubicin—thyroid cancer	0.000524	0.00154	CcSEcCtD
Eletriptan—Osteoarthritis—Doxorubicin—thyroid cancer	0.000515	0.00151	CcSEcCtD
Eletriptan—Diplopia—Doxorubicin—thyroid cancer	0.000515	0.00151	CcSEcCtD
Eletriptan—Liver function test abnormal—Epirubicin—thyroid cancer	0.000514	0.00151	CcSEcCtD
Eletriptan—Dry skin—Epirubicin—thyroid cancer	0.000511	0.0015	CcSEcCtD
Eletriptan—Abdominal pain upper—Epirubicin—thyroid cancer	0.000509	0.00149	CcSEcCtD
Eletriptan—Affect lability—Doxorubicin—thyroid cancer	0.000507	0.00149	CcSEcCtD
Eletriptan—Migraine—Doxorubicin—thyroid cancer	0.000507	0.00149	CcSEcCtD
Eletriptan—Diarrhoea—Sorafenib—thyroid cancer	0.000507	0.00149	CcSEcCtD
Eletriptan—Face oedema—Doxorubicin—thyroid cancer	0.000498	0.00146	CcSEcCtD
Eletriptan—Gastritis—Epirubicin—thyroid cancer	0.000493	0.00145	CcSEcCtD
Eletriptan—Muscular weakness—Epirubicin—thyroid cancer	0.000491	0.00144	CcSEcCtD
Eletriptan—Dizziness—Sorafenib—thyroid cancer	0.00049	0.00144	CcSEcCtD
Eletriptan—Mood swings—Doxorubicin—thyroid cancer	0.000488	0.00143	CcSEcCtD
Eletriptan—Abdominal distension—Epirubicin—thyroid cancer	0.000485	0.00142	CcSEcCtD
Eletriptan—Ataxia—Doxorubicin—thyroid cancer	0.000485	0.00142	CcSEcCtD
Eletriptan—Influenza—Epirubicin—thyroid cancer	0.000482	0.00141	CcSEcCtD
Eletriptan—Asthma—Epirubicin—thyroid cancer	0.000482	0.00141	CcSEcCtD
Eletriptan—Dysphagia—Epirubicin—thyroid cancer	0.000482	0.00141	CcSEcCtD
Eletriptan—Liver function test abnormal—Doxorubicin—thyroid cancer	0.000476	0.0014	CcSEcCtD
Eletriptan—Dry skin—Doxorubicin—thyroid cancer	0.000473	0.00139	CcSEcCtD
Eletriptan—Vomiting—Sorafenib—thyroid cancer	0.000471	0.00138	CcSEcCtD
Eletriptan—Abdominal pain upper—Doxorubicin—thyroid cancer	0.000471	0.00138	CcSEcCtD
Eletriptan—Angina pectoris—Epirubicin—thyroid cancer	0.000469	0.00138	CcSEcCtD
Eletriptan—Rash—Sorafenib—thyroid cancer	0.000467	0.00137	CcSEcCtD
Eletriptan—Dermatitis—Sorafenib—thyroid cancer	0.000467	0.00137	CcSEcCtD
Eletriptan—Headache—Sorafenib—thyroid cancer	0.000464	0.00136	CcSEcCtD
Eletriptan—Bronchitis—Epirubicin—thyroid cancer	0.000463	0.00136	CcSEcCtD
Eletriptan—Gastritis—Doxorubicin—thyroid cancer	0.000456	0.00134	CcSEcCtD
Eletriptan—Muscular weakness—Doxorubicin—thyroid cancer	0.000455	0.00133	CcSEcCtD
Eletriptan—Abdominal distension—Doxorubicin—thyroid cancer	0.000449	0.00132	CcSEcCtD
Eletriptan—Influenza—Doxorubicin—thyroid cancer	0.000446	0.00131	CcSEcCtD
Eletriptan—Asthma—Doxorubicin—thyroid cancer	0.000446	0.00131	CcSEcCtD
Eletriptan—Dysphagia—Doxorubicin—thyroid cancer	0.000446	0.00131	CcSEcCtD
Eletriptan—Pollakiuria—Epirubicin—thyroid cancer	0.000445	0.00131	CcSEcCtD
Eletriptan—Nausea—Sorafenib—thyroid cancer	0.00044	0.00129	CcSEcCtD
Eletriptan—Weight increased—Epirubicin—thyroid cancer	0.000438	0.00129	CcSEcCtD
Eletriptan—Weight decreased—Epirubicin—thyroid cancer	0.000436	0.00128	CcSEcCtD
Eletriptan—Hyperglycaemia—Epirubicin—thyroid cancer	0.000434	0.00128	CcSEcCtD
Eletriptan—Angina pectoris—Doxorubicin—thyroid cancer	0.000434	0.00127	CcSEcCtD
Eletriptan—Drowsiness—Epirubicin—thyroid cancer	0.000429	0.00126	CcSEcCtD
Eletriptan—Bronchitis—Doxorubicin—thyroid cancer	0.000428	0.00126	CcSEcCtD
Eletriptan—Neuropathy peripheral—Epirubicin—thyroid cancer	0.000421	0.00124	CcSEcCtD
Eletriptan—Stomatitis—Epirubicin—thyroid cancer	0.000418	0.00123	CcSEcCtD
Eletriptan—Conjunctivitis—Epirubicin—thyroid cancer	0.000417	0.00123	CcSEcCtD
Eletriptan—Sweating—Epirubicin—thyroid cancer	0.000412	0.00121	CcSEcCtD
Eletriptan—Pollakiuria—Doxorubicin—thyroid cancer	0.000412	0.00121	CcSEcCtD
Eletriptan—Weight increased—Doxorubicin—thyroid cancer	0.000405	0.00119	CcSEcCtD
Eletriptan—Epistaxis—Epirubicin—thyroid cancer	0.000405	0.00119	CcSEcCtD
Eletriptan—Weight decreased—Doxorubicin—thyroid cancer	0.000403	0.00118	CcSEcCtD
Eletriptan—Sinusitis—Epirubicin—thyroid cancer	0.000403	0.00118	CcSEcCtD
Eletriptan—Hyperglycaemia—Doxorubicin—thyroid cancer	0.000402	0.00118	CcSEcCtD
Eletriptan—Drowsiness—Doxorubicin—thyroid cancer	0.000397	0.00117	CcSEcCtD
Eletriptan—Bradycardia—Epirubicin—thyroid cancer	0.000392	0.00115	CcSEcCtD
Eletriptan—Neuropathy peripheral—Doxorubicin—thyroid cancer	0.000389	0.00114	CcSEcCtD
Eletriptan—Stomatitis—Doxorubicin—thyroid cancer	0.000387	0.00114	CcSEcCtD
Eletriptan—Rhinitis—Epirubicin—thyroid cancer	0.000386	0.00113	CcSEcCtD
Eletriptan—Conjunctivitis—Doxorubicin—thyroid cancer	0.000386	0.00113	CcSEcCtD
Eletriptan—Hypoaesthesia—Epirubicin—thyroid cancer	0.000383	0.00113	CcSEcCtD
Eletriptan—Pharyngitis—Epirubicin—thyroid cancer	0.000383	0.00112	CcSEcCtD
Eletriptan—Sweating—Doxorubicin—thyroid cancer	0.000381	0.00112	CcSEcCtD
Eletriptan—Urinary tract disorder—Epirubicin—thyroid cancer	0.000381	0.00112	CcSEcCtD
Eletriptan—Oedema peripheral—Epirubicin—thyroid cancer	0.00038	0.00111	CcSEcCtD
Eletriptan—Urethral disorder—Epirubicin—thyroid cancer	0.000378	0.00111	CcSEcCtD
Eletriptan—Epistaxis—Doxorubicin—thyroid cancer	0.000375	0.0011	CcSEcCtD
Eletriptan—Sinusitis—Doxorubicin—thyroid cancer	0.000373	0.00109	CcSEcCtD
Eletriptan—Visual impairment—Epirubicin—thyroid cancer	0.000371	0.00109	CcSEcCtD
Eletriptan—Bradycardia—Doxorubicin—thyroid cancer	0.000363	0.00107	CcSEcCtD
Eletriptan—Tinnitus—Epirubicin—thyroid cancer	0.000359	0.00105	CcSEcCtD
Eletriptan—Flushing—Epirubicin—thyroid cancer	0.000358	0.00105	CcSEcCtD
Eletriptan—Rhinitis—Doxorubicin—thyroid cancer	0.000358	0.00105	CcSEcCtD
Eletriptan—Hypoaesthesia—Doxorubicin—thyroid cancer	0.000355	0.00104	CcSEcCtD
Eletriptan—Pharyngitis—Doxorubicin—thyroid cancer	0.000354	0.00104	CcSEcCtD
Eletriptan—Urinary tract disorder—Doxorubicin—thyroid cancer	0.000352	0.00103	CcSEcCtD
Eletriptan—Oedema peripheral—Doxorubicin—thyroid cancer	0.000351	0.00103	CcSEcCtD
Eletriptan—Urethral disorder—Doxorubicin—thyroid cancer	0.00035	0.00103	CcSEcCtD
Eletriptan—Immune system disorder—Epirubicin—thyroid cancer	0.000348	0.00102	CcSEcCtD
Eletriptan—Chills—Epirubicin—thyroid cancer	0.000346	0.00102	CcSEcCtD
Eletriptan—Arrhythmia—Epirubicin—thyroid cancer	0.000344	0.00101	CcSEcCtD
Eletriptan—Visual impairment—Doxorubicin—thyroid cancer	0.000344	0.00101	CcSEcCtD
Eletriptan—Alopecia—Epirubicin—thyroid cancer	0.000341	0.001	CcSEcCtD
Eletriptan—Tinnitus—Doxorubicin—thyroid cancer	0.000332	0.000976	CcSEcCtD
Eletriptan—Flushing—Doxorubicin—thyroid cancer	0.000331	0.000972	CcSEcCtD
Eletriptan—Flatulence—Epirubicin—thyroid cancer	0.000331	0.00097	CcSEcCtD
Eletriptan—Tension—Epirubicin—thyroid cancer	0.000329	0.000966	CcSEcCtD
Eletriptan—Dysgeusia—Epirubicin—thyroid cancer	0.000329	0.000964	CcSEcCtD
Eletriptan—Nervousness—Epirubicin—thyroid cancer	0.000326	0.000957	CcSEcCtD
Eletriptan—Back pain—Epirubicin—thyroid cancer	0.000325	0.000953	CcSEcCtD
Eletriptan—Muscle spasms—Epirubicin—thyroid cancer	0.000323	0.000947	CcSEcCtD
Eletriptan—Immune system disorder—Doxorubicin—thyroid cancer	0.000322	0.000946	CcSEcCtD
Eletriptan—Chills—Doxorubicin—thyroid cancer	0.00032	0.000939	CcSEcCtD
Eletriptan—Arrhythmia—Doxorubicin—thyroid cancer	0.000319	0.000935	CcSEcCtD
Eletriptan—Alopecia—Doxorubicin—thyroid cancer	0.000315	0.000925	CcSEcCtD
Eletriptan—Ill-defined disorder—Epirubicin—thyroid cancer	0.000311	0.000914	CcSEcCtD
Eletriptan—Anaemia—Epirubicin—thyroid cancer	0.00031	0.00091	CcSEcCtD
Eletriptan—Agitation—Epirubicin—thyroid cancer	0.000308	0.000905	CcSEcCtD
Eletriptan—Flatulence—Doxorubicin—thyroid cancer	0.000306	0.000898	CcSEcCtD
Eletriptan—Tension—Doxorubicin—thyroid cancer	0.000305	0.000894	CcSEcCtD
Eletriptan—Dysgeusia—Doxorubicin—thyroid cancer	0.000304	0.000892	CcSEcCtD
Eletriptan—Malaise—Epirubicin—thyroid cancer	0.000303	0.000888	CcSEcCtD
Eletriptan—Nervousness—Doxorubicin—thyroid cancer	0.000302	0.000885	CcSEcCtD
Eletriptan—Vertigo—Epirubicin—thyroid cancer	0.000301	0.000885	CcSEcCtD
Eletriptan—Syncope—Epirubicin—thyroid cancer	0.000301	0.000883	CcSEcCtD
Eletriptan—Leukopenia—Epirubicin—thyroid cancer	0.0003	0.000882	CcSEcCtD
Eletriptan—Back pain—Doxorubicin—thyroid cancer	0.0003	0.000881	CcSEcCtD
Eletriptan—Muscle spasms—Doxorubicin—thyroid cancer	0.000298	0.000876	CcSEcCtD
Eletriptan—Palpitations—Epirubicin—thyroid cancer	0.000296	0.00087	CcSEcCtD
Eletriptan—Loss of consciousness—Epirubicin—thyroid cancer	0.000295	0.000866	CcSEcCtD
Eletriptan—Cough—Epirubicin—thyroid cancer	0.000293	0.000859	CcSEcCtD
Eletriptan—Convulsion—Epirubicin—thyroid cancer	0.000291	0.000853	CcSEcCtD
Eletriptan—Hypertension—Epirubicin—thyroid cancer	0.00029	0.00085	CcSEcCtD
Eletriptan—Ill-defined disorder—Doxorubicin—thyroid cancer	0.000288	0.000846	CcSEcCtD
Eletriptan—Anaemia—Doxorubicin—thyroid cancer	0.000287	0.000842	CcSEcCtD
Eletriptan—Arthralgia—Epirubicin—thyroid cancer	0.000286	0.000838	CcSEcCtD
Eletriptan—Myalgia—Epirubicin—thyroid cancer	0.000286	0.000838	CcSEcCtD
Eletriptan—Agitation—Doxorubicin—thyroid cancer	0.000285	0.000837	CcSEcCtD
Eletriptan—Anxiety—Epirubicin—thyroid cancer	0.000285	0.000836	CcSEcCtD
Eletriptan—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—thyroid cancer	0.000284	0.000833	CcSEcCtD
Eletriptan—Discomfort—Epirubicin—thyroid cancer	0.000282	0.000828	CcSEcCtD
Eletriptan—Malaise—Doxorubicin—thyroid cancer	0.00028	0.000822	CcSEcCtD
Eletriptan—Dry mouth—Epirubicin—thyroid cancer	0.000279	0.00082	CcSEcCtD
Eletriptan—Vertigo—Doxorubicin—thyroid cancer	0.000279	0.000819	CcSEcCtD
Eletriptan—Syncope—Doxorubicin—thyroid cancer	0.000278	0.000817	CcSEcCtD
Eletriptan—Leukopenia—Doxorubicin—thyroid cancer	0.000278	0.000816	CcSEcCtD
Eletriptan—Confusional state—Epirubicin—thyroid cancer	0.000276	0.00081	CcSEcCtD
Eletriptan—Palpitations—Doxorubicin—thyroid cancer	0.000274	0.000805	CcSEcCtD
Eletriptan—Oedema—Epirubicin—thyroid cancer	0.000274	0.000804	CcSEcCtD
Eletriptan—Loss of consciousness—Doxorubicin—thyroid cancer	0.000273	0.000801	CcSEcCtD
Eletriptan—Cough—Doxorubicin—thyroid cancer	0.000271	0.000795	CcSEcCtD
Eletriptan—Shock—Epirubicin—thyroid cancer	0.000269	0.000791	CcSEcCtD
Eletriptan—Convulsion—Doxorubicin—thyroid cancer	0.000269	0.00079	CcSEcCtD
Eletriptan—Nervous system disorder—Epirubicin—thyroid cancer	0.000269	0.000788	CcSEcCtD
Eletriptan—Hypertension—Doxorubicin—thyroid cancer	0.000268	0.000787	CcSEcCtD
Eletriptan—Tachycardia—Epirubicin—thyroid cancer	0.000267	0.000784	CcSEcCtD
Eletriptan—Skin disorder—Epirubicin—thyroid cancer	0.000266	0.000781	CcSEcCtD
Eletriptan—Hyperhidrosis—Epirubicin—thyroid cancer	0.000265	0.000777	CcSEcCtD
Eletriptan—Arthralgia—Doxorubicin—thyroid cancer	0.000264	0.000776	CcSEcCtD
Eletriptan—Myalgia—Doxorubicin—thyroid cancer	0.000264	0.000776	CcSEcCtD
Eletriptan—Anxiety—Doxorubicin—thyroid cancer	0.000263	0.000773	CcSEcCtD
Eletriptan—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—thyroid cancer	0.000262	0.00077	CcSEcCtD
Eletriptan—Discomfort—Doxorubicin—thyroid cancer	0.000261	0.000767	CcSEcCtD
Eletriptan—Anorexia—Epirubicin—thyroid cancer	0.000261	0.000766	CcSEcCtD
Eletriptan—Dry mouth—Doxorubicin—thyroid cancer	0.000258	0.000759	CcSEcCtD
Eletriptan—Hypotension—Epirubicin—thyroid cancer	0.000256	0.000751	CcSEcCtD
Eletriptan—Confusional state—Doxorubicin—thyroid cancer	0.000255	0.00075	CcSEcCtD
Eletriptan—Oedema—Doxorubicin—thyroid cancer	0.000253	0.000744	CcSEcCtD
Eletriptan—Musculoskeletal discomfort—Epirubicin—thyroid cancer	0.000249	0.000732	CcSEcCtD
Eletriptan—Shock—Doxorubicin—thyroid cancer	0.000249	0.000732	CcSEcCtD
Eletriptan—Nervous system disorder—Doxorubicin—thyroid cancer	0.000248	0.000729	CcSEcCtD
Eletriptan—Insomnia—Epirubicin—thyroid cancer	0.000248	0.000727	CcSEcCtD
Eletriptan—Tachycardia—Doxorubicin—thyroid cancer	0.000247	0.000726	CcSEcCtD
Eletriptan—Skin disorder—Doxorubicin—thyroid cancer	0.000246	0.000722	CcSEcCtD
Eletriptan—Paraesthesia—Epirubicin—thyroid cancer	0.000246	0.000722	CcSEcCtD
Eletriptan—Hyperhidrosis—Doxorubicin—thyroid cancer	0.000245	0.000719	CcSEcCtD
Eletriptan—Dyspnoea—Epirubicin—thyroid cancer	0.000244	0.000717	CcSEcCtD
Eletriptan—Somnolence—Epirubicin—thyroid cancer	0.000243	0.000715	CcSEcCtD
Eletriptan—Anorexia—Doxorubicin—thyroid cancer	0.000242	0.000709	CcSEcCtD
Eletriptan—Dyspepsia—Epirubicin—thyroid cancer	0.000241	0.000708	CcSEcCtD
Eletriptan—Decreased appetite—Epirubicin—thyroid cancer	0.000238	0.000699	CcSEcCtD
Eletriptan—Hypotension—Doxorubicin—thyroid cancer	0.000237	0.000695	CcSEcCtD
Eletriptan—Gastrointestinal disorder—Epirubicin—thyroid cancer	0.000236	0.000694	CcSEcCtD
Eletriptan—Fatigue—Epirubicin—thyroid cancer	0.000236	0.000693	CcSEcCtD
Eletriptan—Pain—Epirubicin—thyroid cancer	0.000234	0.000687	CcSEcCtD
Eletriptan—Constipation—Epirubicin—thyroid cancer	0.000234	0.000687	CcSEcCtD
Eletriptan—Musculoskeletal discomfort—Doxorubicin—thyroid cancer	0.000231	0.000678	CcSEcCtD
Eletriptan—Insomnia—Doxorubicin—thyroid cancer	0.000229	0.000673	CcSEcCtD
Eletriptan—Paraesthesia—Doxorubicin—thyroid cancer	0.000228	0.000668	CcSEcCtD
Eletriptan—Dyspnoea—Doxorubicin—thyroid cancer	0.000226	0.000663	CcSEcCtD
Eletriptan—Feeling abnormal—Epirubicin—thyroid cancer	0.000226	0.000662	CcSEcCtD
Eletriptan—Somnolence—Doxorubicin—thyroid cancer	0.000225	0.000661	CcSEcCtD
Eletriptan—Gastrointestinal pain—Epirubicin—thyroid cancer	0.000224	0.000657	CcSEcCtD
Eletriptan—Dyspepsia—Doxorubicin—thyroid cancer	0.000223	0.000655	CcSEcCtD
Eletriptan—Decreased appetite—Doxorubicin—thyroid cancer	0.00022	0.000647	CcSEcCtD
Eletriptan—Gastrointestinal disorder—Doxorubicin—thyroid cancer	0.000219	0.000642	CcSEcCtD
Eletriptan—Fatigue—Doxorubicin—thyroid cancer	0.000218	0.000641	CcSEcCtD
Eletriptan—Urticaria—Epirubicin—thyroid cancer	0.000218	0.000639	CcSEcCtD
Eletriptan—Pain—Doxorubicin—thyroid cancer	0.000217	0.000636	CcSEcCtD
Eletriptan—Constipation—Doxorubicin—thyroid cancer	0.000217	0.000636	CcSEcCtD
Eletriptan—Abdominal pain—Epirubicin—thyroid cancer	0.000216	0.000635	CcSEcCtD
Eletriptan—Body temperature increased—Epirubicin—thyroid cancer	0.000216	0.000635	CcSEcCtD
Eletriptan—Feeling abnormal—Doxorubicin—thyroid cancer	0.000209	0.000613	CcSEcCtD
Eletriptan—Gastrointestinal pain—Doxorubicin—thyroid cancer	0.000207	0.000608	CcSEcCtD
Eletriptan—Hypersensitivity—Epirubicin—thyroid cancer	0.000202	0.000592	CcSEcCtD
Eletriptan—Urticaria—Doxorubicin—thyroid cancer	0.000201	0.000591	CcSEcCtD
Eletriptan—Abdominal pain—Doxorubicin—thyroid cancer	0.0002	0.000588	CcSEcCtD
Eletriptan—Body temperature increased—Doxorubicin—thyroid cancer	0.0002	0.000588	CcSEcCtD
Eletriptan—Asthenia—Epirubicin—thyroid cancer	0.000196	0.000577	CcSEcCtD
Eletriptan—Pruritus—Epirubicin—thyroid cancer	0.000194	0.000569	CcSEcCtD
Eletriptan—Diarrhoea—Epirubicin—thyroid cancer	0.000187	0.00055	CcSEcCtD
Eletriptan—Hypersensitivity—Doxorubicin—thyroid cancer	0.000187	0.000548	CcSEcCtD
Eletriptan—Asthenia—Doxorubicin—thyroid cancer	0.000182	0.000534	CcSEcCtD
Eletriptan—Dizziness—Epirubicin—thyroid cancer	0.000181	0.000532	CcSEcCtD
Eletriptan—Pruritus—Doxorubicin—thyroid cancer	0.000179	0.000526	CcSEcCtD
Eletriptan—Vomiting—Epirubicin—thyroid cancer	0.000174	0.000511	CcSEcCtD
Eletriptan—Diarrhoea—Doxorubicin—thyroid cancer	0.000173	0.000509	CcSEcCtD
Eletriptan—Rash—Epirubicin—thyroid cancer	0.000173	0.000507	CcSEcCtD
Eletriptan—Dermatitis—Epirubicin—thyroid cancer	0.000172	0.000506	CcSEcCtD
Eletriptan—Headache—Epirubicin—thyroid cancer	0.000172	0.000504	CcSEcCtD
Eletriptan—Dizziness—Doxorubicin—thyroid cancer	0.000168	0.000492	CcSEcCtD
Eletriptan—Nausea—Epirubicin—thyroid cancer	0.000163	0.000477	CcSEcCtD
Eletriptan—Vomiting—Doxorubicin—thyroid cancer	0.000161	0.000473	CcSEcCtD
Eletriptan—Rash—Doxorubicin—thyroid cancer	0.00016	0.000469	CcSEcCtD
Eletriptan—Dermatitis—Doxorubicin—thyroid cancer	0.00016	0.000468	CcSEcCtD
Eletriptan—Headache—Doxorubicin—thyroid cancer	0.000159	0.000466	CcSEcCtD
Eletriptan—Nausea—Doxorubicin—thyroid cancer	0.00015	0.000442	CcSEcCtD
Eletriptan—HTR1A—Signaling by GPCR—PTCH1—thyroid cancer	6.82e-05	0.000895	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism—CHST14—thyroid cancer	6.81e-05	0.000894	CbGpPWpGaD
Eletriptan—HTR1F—Signaling Pathways—CDK1—thyroid cancer	6.73e-05	0.000883	CbGpPWpGaD
Eletriptan—HTR2B—Signaling by GPCR—CDK1—thyroid cancer	6.7e-05	0.000879	CbGpPWpGaD
Eletriptan—CYP2D6—Metabolism—NDUFA13—thyroid cancer	6.66e-05	0.000875	CbGpPWpGaD
Eletriptan—ABCB1—Metabolism—CHST14—thyroid cancer	6.65e-05	0.000873	CbGpPWpGaD
Eletriptan—HTR1A—GPCR downstream signaling—CALCA—thyroid cancer	6.61e-05	0.000868	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism—NDUFA13—thyroid cancer	6.61e-05	0.000867	CbGpPWpGaD
Eletriptan—ABCB1—Transmembrane transport of small molecules—CP—thyroid cancer	6.57e-05	0.000863	CbGpPWpGaD
Eletriptan—ABCB1—Transmembrane transport of small molecules—TPR—thyroid cancer	6.57e-05	0.000863	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—TCF7L1—thyroid cancer	6.47e-05	0.000849	CbGpPWpGaD
Eletriptan—ABCB1—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	6.47e-05	0.000849	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—TSHR—thyroid cancer	6.39e-05	0.000839	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—TSHR—thyroid cancer	6.35e-05	0.000833	CbGpPWpGaD
Eletriptan—HTR1E—Signaling Pathways—CDK1—thyroid cancer	6.35e-05	0.000833	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—PRKAR1A—thyroid cancer	6.29e-05	0.000825	CbGpPWpGaD
Eletriptan—CYP2D6—Metabolism—CHST14—thyroid cancer	6.26e-05	0.000823	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—PRKAR1A—thyroid cancer	6.25e-05	0.00082	CbGpPWpGaD
Eletriptan—HTR1A—Signaling by GPCR—SST—thyroid cancer	6.23e-05	0.000818	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—TSHR—thyroid cancer	6.22e-05	0.000816	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism—CHST14—thyroid cancer	6.21e-05	0.000815	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—PRKAR1A—thyroid cancer	6.12e-05	0.000803	CbGpPWpGaD
Eletriptan—ABCB1—HIF-1-alpha transcription factor network—AKT1—thyroid cancer	6.08e-05	0.000798	CbGpPWpGaD
Eletriptan—HTR2B—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—thyroid cancer	6.07e-05	0.000797	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—MEN1—thyroid cancer	6.01e-05	0.000789	CbGpPWpGaD
Eletriptan—HTR1A—Signaling by GPCR—CALCA—thyroid cancer	6e-05	0.000788	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—MEN1—thyroid cancer	5.97e-05	0.000784	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—MEN1—thyroid cancer	5.84e-05	0.000767	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—TSHR—thyroid cancer	5.84e-05	0.000767	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—PRKAR1A—thyroid cancer	5.74e-05	0.000754	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism—HPGD—thyroid cancer	5.49e-05	0.000721	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—MEN1—thyroid cancer	5.49e-05	0.000721	CbGpPWpGaD
Eletriptan—PTGS1—Metabolism—TPR—thyroid cancer	5.47e-05	0.000718	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—PTCH1—thyroid cancer	5.43e-05	0.000713	CbGpPWpGaD
Eletriptan—HTR1A—Signaling by GPCR—CDK1—thyroid cancer	5.43e-05	0.000713	CbGpPWpGaD
Eletriptan—HTR1F—Signaling Pathways—NRG1—thyroid cancer	5.4e-05	0.000709	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—PTCH1—thyroid cancer	5.4e-05	0.000709	CbGpPWpGaD
Eletriptan—PTGS1—Metabolism—PRKAR1A—thyroid cancer	5.38e-05	0.000706	CbGpPWpGaD
Eletriptan—ABCB1—Metabolism—HPGD—thyroid cancer	5.36e-05	0.000704	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—PTCH1—thyroid cancer	5.29e-05	0.000694	CbGpPWpGaD
Eletriptan—CYP2A6—Metabolism—TPR—thyroid cancer	5.17e-05	0.000679	CbGpPWpGaD
Eletriptan—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—thyroid cancer	5.17e-05	0.000679	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—MINPP1—thyroid cancer	5.12e-05	0.000673	CbGpPWpGaD
Eletriptan—HTR1E—Signaling Pathways—NRG1—thyroid cancer	5.09e-05	0.000669	CbGpPWpGaD
Eletriptan—CYP2A6—Metabolism—PRKAR1A—thyroid cancer	5.09e-05	0.000668	CbGpPWpGaD
Eletriptan—CYP2D6—Metabolism—HPGD—thyroid cancer	5.05e-05	0.000663	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism—HPGD—thyroid cancer	5.01e-05	0.000657	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—SST—thyroid cancer	4.97e-05	0.000652	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—PTCH1—thyroid cancer	4.97e-05	0.000652	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—SST—thyroid cancer	4.94e-05	0.000648	CbGpPWpGaD
Eletriptan—ABCB1—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	4.92e-05	0.000646	CbGpPWpGaD
Eletriptan—PTGS1—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	4.88e-05	0.00064	CbGpPWpGaD
Eletriptan—HTR1F—Signaling Pathways—TERT—thyroid cancer	4.85e-05	0.000637	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—SST—thyroid cancer	4.83e-05	0.000635	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—CALCA—thyroid cancer	4.78e-05	0.000628	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—CALCA—thyroid cancer	4.75e-05	0.000624	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—TSHR—thyroid cancer	4.74e-05	0.000622	CbGpPWpGaD
Eletriptan—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—thyroid cancer	4.67e-05	0.000613	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—PRKAR1A—thyroid cancer	4.66e-05	0.000612	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—CALCA—thyroid cancer	4.65e-05	0.000611	CbGpPWpGaD
Eletriptan—HTR1F—Signaling Pathways—HIF1A—thyroid cancer	4.64e-05	0.000609	CbGpPWpGaD
Eletriptan—HTR1E—Signaling Pathways—TERT—thyroid cancer	4.57e-05	0.0006	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—SST—thyroid cancer	4.54e-05	0.000596	CbGpPWpGaD
Eletriptan—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—thyroid cancer	4.51e-05	0.000592	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	4.45e-05	0.000585	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—MEN1—thyroid cancer	4.45e-05	0.000585	CbGpPWpGaD
Eletriptan—HTR1E—Signaling Pathways—HIF1A—thyroid cancer	4.37e-05	0.000574	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—CALCA—thyroid cancer	4.37e-05	0.000574	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—NDUFA13—thyroid cancer	4.36e-05	0.000572	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—CDK1—thyroid cancer	4.33e-05	0.000568	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—CDK1—thyroid cancer	4.3e-05	0.000565	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—CDK1—thyroid cancer	4.21e-05	0.000553	CbGpPWpGaD
Eletriptan—ABCB1—Transmembrane transport of small molecules—RXRA—thyroid cancer	4.13e-05	0.000543	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—CHST14—thyroid cancer	4.1e-05	0.000538	CbGpPWpGaD
Eletriptan—PTGS1—Metabolism—SLC5A5—thyroid cancer	4.09e-05	0.000538	CbGpPWpGaD
Eletriptan—HTR1F—Signaling by GPCR—NRAS—thyroid cancer	4.08e-05	0.000536	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	4.06e-05	0.000533	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—PTCH1—thyroid cancer	4.03e-05	0.000529	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—CDK1—thyroid cancer	3.96e-05	0.000519	CbGpPWpGaD
Eletriptan—CYP2A6—Metabolism—SLC5A5—thyroid cancer	3.87e-05	0.000508	CbGpPWpGaD
Eletriptan—HTR1E—Signaling by GPCR—NRAS—thyroid cancer	3.85e-05	0.000506	CbGpPWpGaD
Eletriptan—HTR1F—Signaling Pathways—BRAF—thyroid cancer	3.84e-05	0.000504	CbGpPWpGaD
Eletriptan—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	3.84e-05	0.000504	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—SST—thyroid cancer	3.68e-05	0.000483	CbGpPWpGaD
Eletriptan—HTR1E—Signaling Pathways—BRAF—thyroid cancer	3.62e-05	0.000476	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—CALCA—thyroid cancer	3.54e-05	0.000465	CbGpPWpGaD
Eletriptan—HTR1F—Signaling by GPCR—KRAS—thyroid cancer	3.52e-05	0.000462	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—NRG1—thyroid cancer	3.48e-05	0.000456	CbGpPWpGaD
Eletriptan—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—thyroid cancer	3.46e-05	0.000455	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—NRG1—thyroid cancer	3.45e-05	0.000453	CbGpPWpGaD
Eletriptan—PTGS1—Metabolism—RXRA—thyroid cancer	3.44e-05	0.000452	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—NRG1—thyroid cancer	3.38e-05	0.000444	CbGpPWpGaD
Eletriptan—PTGS1—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	3.35e-05	0.000439	CbGpPWpGaD
Eletriptan—HTR1E—Signaling by GPCR—KRAS—thyroid cancer	3.32e-05	0.000435	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—HPGD—thyroid cancer	3.3e-05	0.000433	CbGpPWpGaD
Eletriptan—CYP2A6—Metabolism—RXRA—thyroid cancer	3.25e-05	0.000427	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—CDK1—thyroid cancer	3.21e-05	0.000421	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—NRG1—thyroid cancer	3.18e-05	0.000417	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism—TPR—thyroid cancer	3.15e-05	0.000414	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—TERT—thyroid cancer	3.12e-05	0.00041	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism—PRKAR1A—thyroid cancer	3.1e-05	0.000407	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—TERT—thyroid cancer	3.1e-05	0.000407	CbGpPWpGaD
Eletriptan—ABCB1—Metabolism—TPR—thyroid cancer	3.08e-05	0.000404	CbGpPWpGaD
Eletriptan—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—thyroid cancer	3.08e-05	0.000404	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—TERT—thyroid cancer	3.04e-05	0.000399	CbGpPWpGaD
Eletriptan—ABCB1—Metabolism—PRKAR1A—thyroid cancer	3.03e-05	0.000398	CbGpPWpGaD
Eletriptan—HTR1F—Signaling by GPCR—HRAS—thyroid cancer	2.99e-05	0.000392	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—HIF1A—thyroid cancer	2.98e-05	0.000392	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—HIF1A—thyroid cancer	2.97e-05	0.000389	CbGpPWpGaD
Eletriptan—HTR1F—GPCR downstream signaling—AKT1—thyroid cancer	2.91e-05	0.000381	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—HIF1A—thyroid cancer	2.9e-05	0.000381	CbGpPWpGaD
Eletriptan—CYP2D6—Metabolism—TPR—thyroid cancer	2.9e-05	0.000381	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism—TPR—thyroid cancer	2.88e-05	0.000378	CbGpPWpGaD
Eletriptan—CYP2D6—Metabolism—PRKAR1A—thyroid cancer	2.85e-05	0.000375	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—TERT—thyroid cancer	2.85e-05	0.000374	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism—PRKAR1A—thyroid cancer	2.83e-05	0.000371	CbGpPWpGaD
Eletriptan—HTR1E—Signaling by GPCR—HRAS—thyroid cancer	2.82e-05	0.00037	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	2.81e-05	0.000369	CbGpPWpGaD
Eletriptan—HTR1F—Signaling Pathways—CCND1—thyroid cancer	2.8e-05	0.000368	CbGpPWpGaD
Eletriptan—HTR1E—GPCR downstream signaling—AKT1—thyroid cancer	2.74e-05	0.00036	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—HIF1A—thyroid cancer	2.73e-05	0.000358	CbGpPWpGaD
Eletriptan—HTR1F—Signaling Pathways—PTEN—thyroid cancer	2.7e-05	0.000355	CbGpPWpGaD
Eletriptan—HTR1E—Signaling Pathways—CCND1—thyroid cancer	2.64e-05	0.000347	CbGpPWpGaD
Eletriptan—HTR1F—Signaling by GPCR—AKT1—thyroid cancer	2.64e-05	0.000346	CbGpPWpGaD
Eletriptan—HTR7—Signaling by GPCR—NRAS—thyroid cancer	2.63e-05	0.000345	CbGpPWpGaD
Eletriptan—HTR1D—Signaling by GPCR—NRAS—thyroid cancer	2.61e-05	0.000343	CbGpPWpGaD
Eletriptan—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—thyroid cancer	2.6e-05	0.000341	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—NRG1—thyroid cancer	2.58e-05	0.000338	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	2.56e-05	0.000337	CbGpPWpGaD
Eletriptan—HTR1B—Signaling by GPCR—NRAS—thyroid cancer	2.56e-05	0.000336	CbGpPWpGaD
Eletriptan—HTR1E—Signaling Pathways—PTEN—thyroid cancer	2.55e-05	0.000335	CbGpPWpGaD
Eletriptan—HTR1E—Signaling by GPCR—AKT1—thyroid cancer	2.49e-05	0.000327	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—BRAF—thyroid cancer	2.47e-05	0.000324	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—BRAF—thyroid cancer	2.46e-05	0.000322	CbGpPWpGaD
Eletriptan—HTR1F—Signaling Pathways—NRAS—thyroid cancer	2.41e-05	0.000317	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—BRAF—thyroid cancer	2.4e-05	0.000316	CbGpPWpGaD
Eletriptan—HTR2B—Signaling by GPCR—NRAS—thyroid cancer	2.4e-05	0.000315	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism—SLC5A5—thyroid cancer	2.36e-05	0.00031	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—TERT—thyroid cancer	2.31e-05	0.000304	CbGpPWpGaD
Eletriptan—ABCB1—Metabolism—SLC5A5—thyroid cancer	2.3e-05	0.000302	CbGpPWpGaD
Eletriptan—HTR1E—Signaling Pathways—NRAS—thyroid cancer	2.28e-05	0.000299	CbGpPWpGaD
Eletriptan—HTR7—Signaling by GPCR—KRAS—thyroid cancer	2.26e-05	0.000297	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—BRAF—thyroid cancer	2.26e-05	0.000297	CbGpPWpGaD
Eletriptan—HTR1D—Signaling by GPCR—KRAS—thyroid cancer	2.25e-05	0.000295	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	2.21e-05	0.00029	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—HIF1A—thyroid cancer	2.21e-05	0.00029	CbGpPWpGaD
Eletriptan—HTR1B—Signaling by GPCR—KRAS—thyroid cancer	2.2e-05	0.000289	CbGpPWpGaD
Eletriptan—PTGS1—Metabolism—PPARG—thyroid cancer	2.17e-05	0.000285	CbGpPWpGaD
Eletriptan—CYP2D6—Metabolism—SLC5A5—thyroid cancer	2.17e-05	0.000285	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism—SLC5A5—thyroid cancer	2.15e-05	0.000283	CbGpPWpGaD
Eletriptan—HTR1F—Signaling Pathways—KRAS—thyroid cancer	2.08e-05	0.000273	CbGpPWpGaD
Eletriptan—HTR2B—Signaling by GPCR—KRAS—thyroid cancer	2.07e-05	0.000271	CbGpPWpGaD
Eletriptan—CYP2A6—Metabolism—PPARG—thyroid cancer	2.05e-05	0.00027	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	2.02e-05	0.000265	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism—RXRA—thyroid cancer	1.98e-05	0.00026	CbGpPWpGaD
Eletriptan—HTR1E—Signaling Pathways—KRAS—thyroid cancer	1.96e-05	0.000257	CbGpPWpGaD
Eletriptan—HTR1A—Signaling by GPCR—NRAS—thyroid cancer	1.95e-05	0.000256	CbGpPWpGaD
Eletriptan—ABCB1—Metabolism—RXRA—thyroid cancer	1.94e-05	0.000254	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	1.93e-05	0.000253	CbGpPWpGaD
Eletriptan—HTR7—Signaling by GPCR—HRAS—thyroid cancer	1.92e-05	0.000253	CbGpPWpGaD
Eletriptan—HTR1D—Signaling by GPCR—HRAS—thyroid cancer	1.91e-05	0.000251	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—TPR—thyroid cancer	1.9e-05	0.000249	CbGpPWpGaD
Eletriptan—HTR1B—Signaling by GPCR—HRAS—thyroid cancer	1.87e-05	0.000246	CbGpPWpGaD
Eletriptan—HTR7—GPCR downstream signaling—AKT1—thyroid cancer	1.87e-05	0.000246	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—PRKAR1A—thyroid cancer	1.87e-05	0.000245	CbGpPWpGaD
Eletriptan—HTR1D—GPCR downstream signaling—AKT1—thyroid cancer	1.86e-05	0.000244	CbGpPWpGaD
Eletriptan—HTR1F—Signaling Pathways—TP53—thyroid cancer	1.85e-05	0.000242	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—BRAF—thyroid cancer	1.83e-05	0.00024	CbGpPWpGaD
Eletriptan—CYP2D6—Metabolism—RXRA—thyroid cancer	1.82e-05	0.00024	CbGpPWpGaD
Eletriptan—HTR1B—GPCR downstream signaling—AKT1—thyroid cancer	1.82e-05	0.000239	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism—RXRA—thyroid cancer	1.81e-05	0.000237	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—CCND1—thyroid cancer	1.8e-05	0.000237	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—CCND1—thyroid cancer	1.79e-05	0.000235	CbGpPWpGaD
Eletriptan—HTR1F—Signaling Pathways—HRAS—thyroid cancer	1.77e-05	0.000232	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	1.76e-05	0.000231	CbGpPWpGaD
Eletriptan—HTR2B—Signaling by GPCR—HRAS—thyroid cancer	1.76e-05	0.000231	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—CCND1—thyroid cancer	1.75e-05	0.00023	CbGpPWpGaD
Eletriptan—HTR1E—Signaling Pathways—TP53—thyroid cancer	1.74e-05	0.000229	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—PTEN—thyroid cancer	1.74e-05	0.000229	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—PTEN—thyroid cancer	1.73e-05	0.000227	CbGpPWpGaD
Eletriptan—HTR2B—GPCR downstream signaling—AKT1—thyroid cancer	1.71e-05	0.000224	CbGpPWpGaD
Eletriptan—PTGS1—Metabolism—PTGS2—thyroid cancer	1.71e-05	0.000224	CbGpPWpGaD
Eletriptan—HTR7—Signaling by GPCR—AKT1—thyroid cancer	1.7e-05	0.000223	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—PTEN—thyroid cancer	1.69e-05	0.000222	CbGpPWpGaD
Eletriptan—HTR1D—Signaling by GPCR—AKT1—thyroid cancer	1.69e-05	0.000222	CbGpPWpGaD
Eletriptan—HTR1A—Signaling by GPCR—KRAS—thyroid cancer	1.68e-05	0.00022	CbGpPWpGaD
Eletriptan—HTR1E—Signaling Pathways—HRAS—thyroid cancer	1.67e-05	0.000219	CbGpPWpGaD
Eletriptan—HTR1B—Signaling by GPCR—AKT1—thyroid cancer	1.65e-05	0.000217	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—CCND1—thyroid cancer	1.65e-05	0.000216	CbGpPWpGaD
Eletriptan—CYP2A6—Metabolism—PTGS2—thyroid cancer	1.62e-05	0.000212	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—PTEN—thyroid cancer	1.59e-05	0.000209	CbGpPWpGaD
Eletriptan—HTR1F—Signaling Pathways—AKT1—thyroid cancer	1.56e-05	0.000205	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—NRAS—thyroid cancer	1.55e-05	0.000204	CbGpPWpGaD
Eletriptan—HTR2B—Signaling by GPCR—AKT1—thyroid cancer	1.55e-05	0.000204	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—NRAS—thyroid cancer	1.54e-05	0.000203	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—NRAS—thyroid cancer	1.51e-05	0.000198	CbGpPWpGaD
Eletriptan—PTGS1—Metabolism—PTEN—thyroid cancer	1.49e-05	0.000196	CbGpPWpGaD
Eletriptan—HTR1E—Signaling Pathways—AKT1—thyroid cancer	1.47e-05	0.000193	CbGpPWpGaD
Eletriptan—HTR1A—Signaling by GPCR—HRAS—thyroid cancer	1.43e-05	0.000187	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—SLC5A5—thyroid cancer	1.42e-05	0.000186	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—NRAS—thyroid cancer	1.42e-05	0.000186	CbGpPWpGaD
Eletriptan—CYP2A6—Metabolism—PTEN—thyroid cancer	1.41e-05	0.000185	CbGpPWpGaD
Eletriptan—HTR1A—GPCR downstream signaling—AKT1—thyroid cancer	1.39e-05	0.000182	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—KRAS—thyroid cancer	1.34e-05	0.000176	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—CCND1—thyroid cancer	1.34e-05	0.000175	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—KRAS—thyroid cancer	1.33e-05	0.000174	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—KRAS—thyroid cancer	1.3e-05	0.000171	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—PTEN—thyroid cancer	1.29e-05	0.000169	CbGpPWpGaD
Eletriptan—HTR1A—Signaling by GPCR—AKT1—thyroid cancer	1.26e-05	0.000165	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism—PPARG—thyroid cancer	1.25e-05	0.000164	CbGpPWpGaD
Eletriptan—ABCB1—Metabolism—PPARG—thyroid cancer	1.22e-05	0.00016	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—KRAS—thyroid cancer	1.22e-05	0.00016	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—RXRA—thyroid cancer	1.19e-05	0.000157	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—TP53—thyroid cancer	1.19e-05	0.000156	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—TP53—thyroid cancer	1.18e-05	0.000155	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—TP53—thyroid cancer	1.16e-05	0.000152	CbGpPWpGaD
Eletriptan—CYP2D6—Metabolism—PPARG—thyroid cancer	1.15e-05	0.000151	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—NRAS—thyroid cancer	1.15e-05	0.000151	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism—PPARG—thyroid cancer	1.14e-05	0.00015	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—HRAS—thyroid cancer	1.14e-05	0.000149	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—HRAS—thyroid cancer	1.13e-05	0.000148	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—HRAS—thyroid cancer	1.11e-05	0.000145	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—TP53—thyroid cancer	1.09e-05	0.000143	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—HRAS—thyroid cancer	1.04e-05	0.000136	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—AKT1—thyroid cancer	1e-05	0.000132	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—AKT1—thyroid cancer	9.97e-06	0.000131	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—KRAS—thyroid cancer	9.91e-06	0.00013	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism—PTGS2—thyroid cancer	9.85e-06	0.000129	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—AKT1—thyroid cancer	9.76e-06	0.000128	CbGpPWpGaD
Eletriptan—ABCB1—Metabolism—PTGS2—thyroid cancer	9.62e-06	0.000126	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—AKT1—thyroid cancer	9.17e-06	0.00012	CbGpPWpGaD
Eletriptan—CYP2D6—Metabolism—PTGS2—thyroid cancer	9.06e-06	0.000119	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism—PTGS2—thyroid cancer	8.98e-06	0.000118	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—TP53—thyroid cancer	8.8e-06	0.000116	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism—PTEN—thyroid cancer	8.59e-06	0.000113	CbGpPWpGaD
Eletriptan—PTGS1—Metabolism—AKT1—thyroid cancer	8.59e-06	0.000113	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—HRAS—thyroid cancer	8.42e-06	0.000111	CbGpPWpGaD
Eletriptan—ABCB1—Metabolism—PTEN—thyroid cancer	8.39e-06	0.00011	CbGpPWpGaD
Eletriptan—CYP2A6—Metabolism—AKT1—thyroid cancer	8.12e-06	0.000107	CbGpPWpGaD
Eletriptan—CYP2D6—Metabolism—PTEN—thyroid cancer	7.9e-06	0.000104	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism—PTEN—thyroid cancer	7.83e-06	0.000103	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—PPARG—thyroid cancer	7.53e-06	9.89e-05	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—AKT1—thyroid cancer	7.44e-06	9.76e-05	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—PTGS2—thyroid cancer	5.92e-06	7.78e-05	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—PTEN—thyroid cancer	5.17e-06	6.78e-05	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism—AKT1—thyroid cancer	4.95e-06	6.5e-05	CbGpPWpGaD
Eletriptan—ABCB1—Metabolism—AKT1—thyroid cancer	4.83e-06	6.34e-05	CbGpPWpGaD
Eletriptan—CYP2D6—Metabolism—AKT1—thyroid cancer	4.55e-06	5.98e-05	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism—AKT1—thyroid cancer	4.51e-06	5.93e-05	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—AKT1—thyroid cancer	2.98e-06	3.91e-05	CbGpPWpGaD
